A 12 month study comparing approved 1st line DMT vs Fingolimod in Relapsing Remitting MS patients.
- Patients naive to treatment OR who have been treated with no more than one DMT.
- Strict cardiovascular exclusions.
All cardiac history will be reviewed by study nurse.
- Patients without history of varicella or vaccination may screen 1 month after receiving vaccine.
Learn more about PrefererMS studies at www.rrmsresearchstudy.com